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result in any significant under-dosing of the target, the 
observed differences showed that the rectum broke our 
institutional DVCs during treatment. This is important data 
required to evaluate the robustness of institutional 
procedures for the planning and delivery of patients’ 
treatments. 
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Purpose or Objective: Acceleration in breast cancer 
treatment might become the new standard. As fraction dose 
rises, the importance of correct positioning increases. CBCT 
is time consuming and uses (low dose) radiation. Increasing 
interval between positioning and actual treatment reduces 
precision. We therefore investigated a CBCT technique with 
lower dose and faster acquisition.  
 
Material and Methods: Both standard and fast pre-treatment 
CBCT imaging (STAND and FAST) were performed on XVI 
Elekta ® in a 5-fractions supine and whole breast irradiation 
scheme (5 x 5.7 Gy). The main difference between protocols 
was gantry speed (Table 1). Central dose was measured with 
PTW equipment in a CTDI32 phantom. High resolution (HR) 
and contrast were measured on a Catphan Phantom. Breast 
contour appearance was assessed on a polystyrene breast 
phantom. Fifteen clinical CBCT-images for three patients to 
which FAST or STAND was randomly assigned, were blindly 
scored by a skilled oncologist. A three-level answer had to be 
formulated regarding visibility of 1) all clips, 2) entire breast 
contour, 3) lung/thorax wall edge and 4) excision cavity. 
Answers were decoded: 0: Not at all; 1: Yes, but only with 
guidance of reference CT; 2; Yes clearly, without reference 
CT. 
 
Results: FAST operated at only 53% and 61 % of dose and time 
of STAND. A low HR (3 lp/mm) was the same for FAST and 
STAND. Contrast was assessed for STAND through visibility of 
the largest (15mm) 1% contrast nodule. For FAST, no nodules 
could be distinguished. There was excess-tissue on cranial 
and caudal CBCT breast phantom slices, but to the same 
extent in STAND and FAST. In mid position, breast edge was 
sharp and coincided with reference CT.  
The Patient study reflected a difference in the overall low 
soft tissue contrast for the two protocols. The excision cavity 
was never scored 2, more 1 for STAND and more 0 for FAST 
and was less visible with higher breast density (patient 3). 
Breast contours showed step-wise artifacts near 
inframammary and axillary folds for both protocols. 
Lung/thorax wall edges were scored 2 and 1 but the 
dependency was larger for patient anatomy than for scan 
protocol. All clips were visible: the rather poor HR is however 
sufficient. Streak artifacts due to beam hardening and 
undersampling were apparent in both protocols (Figure 1).  
Even though the noisy and artifact-rich appearance of the 
images, effect on clinical decision making for registration is 
minimal. The stepwise artifacts appear very localized and are 
easily corrected for in the observer’s mind. Additional 
information by outer breast contour and lung-thoracic wall 
edge compensates for this. Distinction between real artifacts 
and excision cavity can be done by comparison with 
reference CT. Clips are always visible and of special 
importance in high density and/or voluminous breasts. 
 
 
 
 
Conclusion: FAST allows the oncologist to register breast 
CBCT. However, with high density or voluminous breasts, 
clips are recommended with the use of FAST. 
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Purpose or Objective: The primary goal of this study was to 
evaluate the residual inter-fraction positioning errors of our 
intra-cranial frameless stereotactic treatment following a six-
degree of freedom (6DOF) correction based on automatic 
bone anatomy matching. A secondary goal was to evaluate 
the intra-fraction motion. 
 
Material and Methods: Since the implementation of the 
stereotactic program at our centre, 13 patients were treated 
with frameless intra-cranial fractionated radiotherapy on a 
Varian TrueBeam STx linear accelerator. All patients had a 
planning CT scan with an immobilization system that 
comprised of a CIVCO head cup, customizable pillow and 
thermoplastic shell. To guide setup, nose to forehead pitch 
was calculated using CT information and reproduced at 
treatment using a digital level. Roll was measured as the 
difference in height at the level of the anterior ear notch and 
reproduced at treatment using the in-room lasers. Two pre-
treatment CBCTs were acquired; the first to correct using 
6DOF bone anatomy matching the initial inter-fraction 
positioning error and the second to assess the residual inter-
fraction error post 6DOF correction. Since our initial 
experience with the first 3 patients, revealed residual inter-
fraction setup errors greater than 1mm, the residual inter-
fraction setup error post 6DOF correction was measured and 
corrected prior each treatment for all remaining 10 patients. 
Due to the technical limitations of Varian’s 6DOF couch (i.e. 
maximum 3 degrees pitch and roll), the correction of the 
residual inter-fraction error was carried out using 4DOF 
automatic bony anatomy matching (i.e. excluding pitch and 
roll due to 3degree limitation). A post-treatment CBCT was 
acquired to determine the intra-fraction motion using 6DOF 
bone anatomy matching. 
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Results: Datasets from 10 patients were obtained for a total 
of 705 CBCT scans – the first 3 patients were excluded from 
the study due to changes in methodology partly through 
treatment. The mean 3D vector of residual setup error post 
first correction (6DOF) was 0.7 ± 0.4 mm (mean ± SD) and the 
maximum 3D vector was 2.2mm. The mean 3D vector of 
residual setup error post second correction (4DOF) was 0.2 ± 
0.1mm and the maximum 3D vector was 0.8mm. The mean 
3D vector of intra-fraction motion was 0.4 ± 0.2mm and the 
maximum 3D vector was 1.3mm. 
 
Conclusion: Incorporating a second correction pre-treatment 
significantly reduced the residual inter-fraction setup error 
from 0.7 ± 0.4 mm to 0.2 ± 0.1mm. The intra-fraction motion 
for this cohort of patients was twice as large as the residual 
inter-fraction setup error. Efforts are currently underway to 
reduce this intra-fraction motion by focusing on 
improvements to the immobilization system. 
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Purpose or Objective: Recently we introduced an improved 
hybrid treatment planning technique for breast with 
simultaneous irradiation of axillary and supraclavicular lymph 
nodes (level I-IV). This technique combines tangential open 
fields with VMAT (RapidArc®, Varian Medical Systems) and 
results in a highly conformal coverage of the lymph node 
region, with a steep dose fall-off towards esophagus and 
thyroid. The purpose of this study is to evaluate the validity 
of this conformal planning technique, with the required setup 
and image guidance. 
 
Material and Methods: Ten patients were included, of which 
8 were treated in Free Breathing and 2 were treated in Deep 
Inspiration Breathhold. Fractionation was 16 x 267 cGy for 
both elective breast and lymph node regions. PTV-margin of 
level I-IV lymph nodes is 5 mm to the medial direction and 
8mm for all other directions (image 1). Daily online setup was 
performed on bony anatomy with 2 orthogonal kV-images and 
subsequent verified with medio-lateral MV field imaging. At 
the level of the PTVnodes setup deviation up to 3mm was 
allowed in lateral direction, in all other directions and for 
the humeral head 5mm was allowed. At the first 3 fractions 
and weekly a CBCT was acquired for verification of the PTV-
coverage of the lymph nodes. All CBCT’s were used offline 
for analysis of the reproducibility of level I-II nodes, level III-
IV nodes, humeral head and bony anatomy. All 160 fractions 
were used for evaluation of the efficiency of the setup and 
imaging procedure. 
 
 
 
Results: A t-test showed a significant relation between the 
position of the humeral head and all the nodes in cranio-
caudal direction (p=<0.001) and for level III-IV also in lateral 
direction (p=0.01). Repositioning was required in 31 fractions 
(19%). This was reduced to 19 fractions (12%) by excluding 1 
patient with positioning problems. Based on the CBCT’s, we 
found that only in 2% of all cases, an off-set of the humeral 
head less than 8mm lead to a deviation of the nodal PTV of 
more than 5mm. Analysis of the CBCT’s also showed that the 
remaining average setup error for level I-II nodes and level 
III-IV nodes was less than 2mm in all directions with SD of 
max 1.6mm in AP direction (Table 1). 
 
 
 
Conclusion: The positioning of the lymph nodes level I-IV can 
be well addressed by the position of the surrounding bony 
anatomy and the humeral head. For the adequate treatment 
of both the lymph node regions and the breast, two 
orthogonal kV-images and MV field imaging are sufficient.  
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Purpose or Objective: Late genitourinary (GU) and 
gastrointestinal (GI) toxicities are the main dose limiting 
factors prostate radiotherapy plans. However, no predictive 
models, and consequently, no consensus guidelines have been 
reported for GU toxicity. One possible explanation is that the 
plan dose-volume histogram (DVH) is not representative of 
the accumulated bladder dose throughout the treatment 
given variability in bladder filling status, motion and set-up 
uncertainties. Modern image guidance techniques, in 
particular the use of cone beam computed tomography 
(CBCT), facilitates reconstruction of the accumulated dose. 
The aim of the study was to compare planned with 
accumulated dose and volume data for the bladder with the 
latter assessed from daily CBCT imaging and deformable 
image registration (DIR). 
 
Material and Methods: Eight subjects presenting with RTOG 
GU Grade 2+toxicity were selected from a cohort of 287 
patients treated for prostate cancer in 2006-2013. Prescribed 
dose was 81Gy in 45 fractions. The 8 subjects were each 
matched to 3 patients without GU toxicity by the following 
criteria: pretreatment GU symptoms (IPSS score), age ± 5y, 
risk group (low, intermediate, high), whole pelvis vs. 
prostate, and use of neoadjuvant ADT. Treatment required 
adherence to a full bladder and empty rectum protocol. Daily 
CBCT was used for patient realignment and to assess bladder 
and rectal filling status. Dose from planning CT was rigidly 
registered to CBCT using recorded daily shifts followed by 
bladder contour propagation from plan CT to the first day 
CBCT and then to the remaining CBCTs using an intensity-
based deformable image registration (DIR) algorithm. Bladder 
contours were corrected manually and the accumulated D10 
and D20 (defined as the highest dose received by a volume up 
to 10 and 20 cm3 of the bladder, respectively) were 
compared to corresponding values from the planned DVH. All 
registrations and DVHs computations were done using MIM 
Maestro 6.4.4 (Mim Software Inc. Cleveland, OH, US). 
 
Results: In the analyzed patients, the bladder volumes in the 
daily CBCTs were found to vary between 62% and 256% of 
that from the planning CT, with a mean difference in volume 
ranging from 63% to 20%. Differences in the compared DVH 
were also observed where D10 was ±2.7%, and D20 ±11.2% of 
the corresponding planned metrics. 
